NCT04219787Active, not recruiting
Different Limb Lengths in Gastric Bypass Surgery
Swiss Multicenter Randomized Controlled Trial on Different Limb Lengths in Gastric Bypass Surgery
Source: ClinicalTrials.gov · Last updated 13 Nov 2023
Brief summary (registry, in English)
Obesity and type 2 diabetes mellitus (T2DM) are reaching epidemic proportions in the developed world. In morbidly obese patients only surgical treatment (bariatric operations) leads to a sustained weight loss and relief of co-morbidities in the majority of patients. One of the most frequently performed operations is the laparoscopic proximal Roux-en-Y gastric bypass (LRYGB). There is still lack of knowledge why some patients respond much better than others to an identically performed procedure. Therefore, a number of variations of this operation have been introduced over the past 50 years. Increasing the length of small bowel being bypassed has the potential to improve the effect of the operation but buries the risk of nutrient deficiencies. The metabolic effect of LRYGB occurs, in part, independently of weight loss. The mechanisms underlying metabolic improvement through metabolic surgery are not yet fully understood.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- First submitted
- 3 Jan 2020
- Start date
- 1 Jun 2020
- Primary completion date
- 30 Nov 2028
- Lead sponsor
- Clarunis - Universitäres Bauchzentrum Basel
- Diseases
- Obesity, High blood pressure, Type 2 diabetes
- NCT number
- NCT04219787
What you commit to
- Study type: Interventional
- Planned participants: 800
- From 1 Jun 2020 to the primary completion date, 30 Nov 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- general contraindications to kind of surgery
- known or suspected non-compliance, drug or alcohol abuse
Other illness
- inability to follow the procedures of the study, e.g. due to language problems, psychological disorders etc. of the participant
- inflammatory bowel disease
Age
- age \< 18 years or \> 65 years
Other
- participation in another study
- BMI \> 60 kg/m2
- height \< 145 cm
- CL length of \< 180 cm as measured intraoperatively
- ASA physical status classification \> III
Who the study is looking for
- informed consent as documented by signature
- patients with BMI of 35 kg/m2 or higher who comply with the regulatory rules for bariatric surgery in Switzerland
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clarunis University Center for Gastrointestinal and Liver Diseases Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.